{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/691f8fc85f27d8c1bf977ceb?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC","description":"<p>Nasal vaccines show new promise for human papillomavirus (HPV) to address cervical cancer and whooping cough. In business news, Korro's stock craters 81% as AATD interim Phase I/II results miss expectations. Additionally, Johnson &amp; Johnson acquires Halda to expand their cancer pipeline while Merck acquires Cidara to boost antivirals. Lastly, the inaugural Genetic Agency Technology Conference (GATC) hosted by Dyno Therapeutics brought together a diverse group of researchers, entrepreneurs, and patient advocates to discuss the mission of genetic agency, or an individual’s ability to take action at the genetic level to live a healthier life.</p><p>&nbsp;</p><p>&nbsp;Join <em>GEN</em> editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.&nbsp;</p><p>&nbsp;</p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base</em>:&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/cancer/cervical-cancer-may-be-treatable-with-intranasal-nanogel-vaccine/\" rel=\"noopener noreferrer\" target=\"_blank\">Cervical Cancer May Be Treatable with Intranasal Nanogel Vaccine </a></p><p><em>GEN</em>, November 15, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/infectious-diseases/novel-nasal-spray-vaccine-for-pertussis-shows-promise/\" rel=\"noopener noreferrer\" target=\"_blank\">Novel Nasal Spray Vaccine for Pertussis Shows Promise </a></p><p>By Corinna Singleman, PhD,<em> GEN</em>, November 12, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/stockwatch-korro-craters-81-on-data-patient-death-sours-analysts-on-intellia/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia </a></p><p>By Alex Philippidis, <em>GENEdge</em>, November 16, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/cancer/jj-expands-cancer-pipeline-with-3b-halda-acquisition/\" rel=\"noopener noreferrer\" target=\"_blank\">J&amp;J Expands Cancer Pipeline with $3B Halda Acquisition </a></p><p>By Alex Philippidis, <em>GENEdge</em>, November 18, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/infectious-diseases/merck-to-acquire-cidara-for-9-2b-bolstering-antiviral-pipeline/\" rel=\"noopener noreferrer\" target=\"_blank\">Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline&nbsp;</a></p><p>By Alex Philippidis, <em>GEN</em>, November 15, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/ai-meets-genetic-agency-at-dyno-gatc-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">AI Meets Genetic Agency at Dyno GATC 2025</a></p><p>By Fay Lin, PhD, <em>GENEdge</em>, November 14, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/genome-editing/genetic-agency-on-display-at-gatc-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">Genetic Agency on Display at GATC 2025</a></p><p>By Kevin Davies, PhD, and Fay Lin, PhD, <em>GEN</em>, November 13, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/dyno-gatc-announces-ai-agents-muscle-capsid-and-manufacturing-partner/\" rel=\"noopener noreferrer\" target=\"_blank\">Dyno GATC Announces AI Agents, Muscle Capsid, and Manufacturing Partner</a></p><p>By Fay Lin, PhD, <em>GEN Edge</em>, November 11, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/category/multimedia/podcasts/touching-base/\" rel=\"noopener noreferrer\" target=\"_blank\">Touching Base Podcast</a>&nbsp;</p><p>Hosted by Corinna Singleman, PhD&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.insideprecisionmedicine.com/category/multimedia/podcasts/\" rel=\"noopener noreferrer\" target=\"_blank\">Behind the Breakthroughs</a>&nbsp;</p><p>Hosted by Jonathan D. Grinstein, PhD</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}